GLP-1 for South Asian Patients: Diabetes Risk & Metabolic Considerations

Introduction

South Asians (people with origins in India, Pakistan, Bangladesh, Sri Lanka, Nepal, and surrounding regions) have one of the highest type 2 diabetes risk profiles of any population worldwide. The prevalence is roughly 2 to 4 times higher than non-Hispanic white populations at any given BMI.

The pattern is so distinct that the WHO and American Diabetes Association recommend a lower BMI threshold for obesity in South Asian populations: 23 instead of 25 for overweight, and 27.5 instead of 30 for obesity. South Asians develop diabetes at lower body weights, with more visceral fat at any given total weight, and with higher rates of metabolic syndrome features.

GLP-1 medications work well in South Asian patients. Trial data and real-world experience consistently show comparable or even greater glycemic and weight loss responses. The cultural and dietary adaptation is the practical work.

At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.

Why Is South Asian Diabetes Risk So High?

A combination of genetic susceptibility, body composition, and dietary patterns. The pattern is consistent across South Asians regardless of country of residence.

Quick Answer: South Asians have 2 to 4 times higher type 2 diabetes risk than non-Hispanic white populations at any BMI

The genetic component is real but complex. Multiple gene variants associated with insulin resistance and beta-cell dysfunction occur at higher frequency in South Asian populations. The TCF7L2 risk variant for type 2 diabetes shows higher penetrance in South Asians.

Body composition is the bigger driver. South Asians have higher percentage body fat at any given BMI compared to European populations, with disproportionate central and visceral fat distribution. This pattern is sometimes called the South Asian phenotype or thin-fat phenotype. A South Asian with BMI 22 can have visceral fat levels equivalent to a European with BMI 27.

The implication is that BMI alone underestimates metabolic risk in South Asians. Waist circumference and waist-to-hip ratio matter more. The cutoffs are also lower: waist circumference above 90 cm in men and 80 cm in women indicates abdominal obesity in South Asians, versus 102 cm and 88 cm in standard cutoffs.

Dietary patterns vary widely across South Asian populations and have shifted toward more refined carbohydrates and processed foods in the past 30 years, contributing to rising diabetes rates.

What BMI Threshold Should South Asians Use for GLP-1 Eligibility?

The FDA approved indications use the standard BMI cutoffs: 30 for obesity or 27 with weight-related comorbidity. South Asian patients may not meet these cutoffs even when metabolic dysfunction is present.

The ADA Standards of Care recommend considering pharmacotherapy for South Asian patients at BMI 23 or higher with metabolic complications, recognizing the lower-BMI risk profile. Many clinicians follow these adjusted thresholds.

In practice, South Asian patients with BMI 25 to 30 and A1C in the prediabetes range, or with metabolic syndrome features, are reasonable candidates for GLP-1 therapy even if they don’t meet the standard BMI cutoff.

Insurance coverage is the practical complication. Most U.S. insurance plans use the standard FDA cutoffs. South Asian patients with BMI 28 and prediabetes may not get coverage despite higher risk than a non-South Asian patient with BMI 32.

The 2024 CMS guidance for cardiovascular risk reduction has expanded access for South Asian patients with established cardiovascular disease, which is common given the high baseline risk.

How Do GLP-1 Medications Perform in South Asian Populations?

Comparable weight loss and slightly greater A1C reduction in some studies. The trial subgroup data is encouraging.

STEP 6 enrolled East Asian populations (including South Asian) and showed 13.2% weight loss with semaglutide at 68 weeks. Comparable to the STEP 1 main population.

SURPASS-AP-Combo enrolled Asian populations with type 2 diabetes and showed tirzepatide reduced A1C by 2.4 to 2.8 points at 40 weeks, with weight loss of 9 to 14%. Both A1C and weight responses were among the highest in the SURPASS program.

A 2023 real-world study from the UK following South Asian patients on semaglutide for 12 months showed 11.4% weight loss, comparable to non-South Asian patients in the same registry.

The biology may favor South Asian patients somewhat. Higher baseline insulin resistance means more room for improvement. Higher visceral fat percentages mean weight loss may produce more metabolic benefit per pound.

How Do I Adapt Traditional Indian or Pakistani Meals for a GLP-1 Diet?

Traditional South Asian diets are flavor-rich and can be adapted with focus on three principles: more protein, less refined carbohydrate, and smaller overall portions.

Protein options that work well: paneer (cottage cheese), Greek yogurt (yogurt or dahi made thicker), dal (lentil preparations) which provide both protein and fiber, eggs (anda), chicken (murgi), fish (machli), and tofu for vegetarian options. Lean ground meat in seekh kebab or kheema preparations works.

Reduce refined carbohydrates: smaller portions of rice, fewer rotis or naan per meal, no parathas with multiple tablespoons of ghee, substitute cauliflower rice for rice when possible.

Whole grain options: brown rice, jowar (sorghum), bajra (pearl millet), or ragi (finger millet) rotis. These were traditional in many regions before refined wheat displaced them.

Vegetables: bhindi (okra), karela (bitter gourd), lauki (bottle gourd), palak (spinach), methi (fenugreek leaves), and the wide range of South Asian vegetables work well. Light tarka (tempering) with minimal oil rather than heavy oil-based preparations.

Cooking oil: substantially reduce. Traditional preparations often use 4-6 tablespoons of oil for a single dish. Cut to 1-2 tablespoons. Avoid deep-frying.

What About Sweets and Special Occasions?

This is the hardest part for many patients. Mithai (sweets) are deeply tied to weddings, religious celebrations, family visits, and seasonal festivals. Diwali, Eid, Holi, weddings, birthdays all center on specific traditional sweets.

The practical approach: one small piece during special occasions rather than abstinence. Most GLP-1 patients find that the appetite suppression and slowed gastric emptying make heavy sweets feel less appealing than expected. One gulab jamun or rasgulla is genuinely satisfying.

The sugar content of traditional sweets is high (often 30-50 g of sugar per piece) but the portions are typically small. One piece of mithai is closer to one cookie in caloric impact, not one slice of cake.

Family gatherings with elaborate sweet spreads can be navigated by taking a single piece, eating it slowly, and engaging with the social ritual rather than the food volume. Most families adjust over time.

Religious fasting periods can complicate medication timing. Ramadan in particular requires planning. The injection itself does not break the fast (no oral intake), but the medication suppresses appetite which can make breaking the fast at iftar uncomfortable. Many patients adjust injection day to early in the fasting period and eat smaller, protein-focused iftar meals.

Key Takeaway: Higher visceral fat percentage at any given total weight drives the metabolic risk

What About Vegetarian and Jain Diets?

Many South Asians are vegetarian. Some are Jain with additional restrictions (no root vegetables, no onion or garlic in stricter traditions). Both can work on a GLP-1 with attention to protein.

Vegetarian protein sources: paneer (cottage cheese), dal in many forms (toor dal, masoor dal, urad dal, chana dal), Greek yogurt or hung curd, tofu, eggs if not strict vegetarian, paneer bhurji, palak paneer, chana masala. Protein powders (whey, soy, pea) are useful supplements.

Achieving 70-90 g of protein per day on a vegetarian diet is feasible with thoughtful planning. The combinations matter: dal with rice provides complete protein, paneer plus chickpeas plus yogurt covers multiple amino acid profiles.

Jain dietary restrictions (no root vegetables, no fermented foods in some traditions, no consumption after sunset) add complexity but do not preclude GLP-1 therapy. Protein from dairy, lentils, and grains can still meet targets.

Some Jain patients fast frequently (paryushan, other religious fasts). GLP-1 medications are well tolerated during religious fasts. The injection does not violate fasting rules.

How Does the GLP-1 Affect Typical South Asian Eating Patterns?

Slowed gastric emptying interacts with several traditional patterns. Large family dinners with multiple dishes can become uncomfortable on GLP-1s. Tea with biscuits or snacks throughout the day can produce small but cumulative GI symptoms.

The chai ritual is mostly compatible with GLP-1 therapy. Black or green tea with minimal sugar is fine. The traditional masala chai with milk is fine in moderation. The cookies, biscuits, namkeen (savory snacks), or sweets that often accompany chai are the part to limit.

Late dinners are common in many South Asian households. Dinner at 9 or 10 PM is normal. On a GLP-1, late heavy dinners can produce reflux and nausea overnight. Shifting dinner earlier, eating lighter at night, and avoiding heavy fats helps.

Snacking culture is significant in many South Asian households. Continuous availability of namkeen, biscuits, and tea-time snacks adds calories without satiety. The appetite suppression from GLP-1s helps but also means that snack quality matters more than ever.

What About Cardiovascular Risk Specifically?

South Asians have premature cardiovascular disease at rates 2 to 3 times higher than European populations, with onset 5 to 10 years earlier. The SELECT trial (Lincoff et al. 2023 NEJM) showing 20% cardiovascular event reduction with semaglutide is particularly relevant for this population.

The South Asian cardiovascular risk profile includes higher rates of type 2 diabetes, central obesity, dyslipidemia (particularly low HDL and high triglycerides), and lipoprotein(a) elevation. Many of these respond to GLP-1 therapy.

The American College of Cardiology recommends earlier and more aggressive cardiovascular risk assessment in South Asian patients. CT calcium scoring is particularly useful given the discrepancy between traditional risk scores and actual risk.

For a South Asian patient with BMI 26, A1C 6.0, and elevated lipoprotein(a), the cardiovascular case for GLP-1 therapy is strong even though they would not meet standard FDA cutoffs by BMI alone.

What Lab Monitoring Is Appropriate?

Standard GLP-1 monitoring plus particular attention to lipids, A1C, and inflammatory markers. The lower threshold for metabolic intervention in South Asians extends to monitoring.

Baseline: complete metabolic panel, lipid panel including lipoprotein(a) (often elevated in South Asians independent of diet), A1C, TSH, vitamin D (deficiency is common in South Asian populations even in sunny climates), vitamin B12 (deficiency is common, particularly in vegetarians).

Follow-up at 6 to 12 weeks: BMP for renal function, A1C, lipid panel. Most patients see meaningful A1C and lipid improvements within 3 months.

Vitamin B12 deficiency is particularly important in South Asian patients on GLP-1s. Baseline deficiency is common (especially in vegetarians), GLP-1 reduces food intake which can worsen deficiency, and metformin (often co-prescribed) further depletes B12. Supplementation is often appropriate.

A TrimRx personalized treatment plan includes appropriate labs at baseline and follow-up.

Bottom line: Traditional Indian and Pakistani diets can be adapted with focus on protein and reduced refined carbs

FAQ

Can I Keep Eating Rice and Roti?

Yes, in smaller portions. Half a cup of rice or one roti per meal fits within GLP-1 eating patterns. Brown rice or whole grain rotis (jowar, bajra, ragi) are better than white rice or refined wheat.

What About Ghee and Oil?

Reduce significantly. Traditional preparations often use 4-6 tablespoons per dish. Cut to 1-2 tablespoons total. Ghee in small amounts is fine; deep-frying and oil-heavy curries are not GLP-1 friendly.

Will the Medication Work If I Am Vegetarian?

Yes. The medication itself is not affected by diet. The dietary adaptation is about protein intake, which is achievable on vegetarian diets with attention.

Can I Take a GLP-1 During Ramadan?

Yes, with planning. The injection does not break the fast. Schedule injection day during a non-fasting period if possible. Eat protein-focused, smaller meals at iftar and suhoor. Hydrate aggressively during non-fasting hours.

What About Ayurvedic Herbs and Supplements?

Most do not interact with GLP-1 medications. Specific herbs like fenugreek (methi) have modest glucose-lowering effects that can add to GLP-1 effects, occasionally producing low glucose in diabetic patients on additional medications. Tell your clinician about all supplements.

Is There a Difference Between Indian, Pakistani, Bangladeshi, and Sri Lankan Diets?

Yes, significant regional variation. The general principles apply across South Asian cuisines: more protein, less refined carb, smaller portions. The specific dishes vary but the adaptation strategies are similar.

How Does This Affect My Children’s Diabetes Risk?

South Asian children of patients with type 2 diabetes have higher risk than the general population. Early lifestyle intervention is appropriate. The DPP showed that lifestyle changes in parents often extend to children’s habits, providing intergenerational benefit.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.